Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11059 studies found for:    "Lung Diseases"
Show Display Options
Rank Status Study
1 Completed Lung Disease Collection (Qatar): Evaluation of the Lungs of Individuals With Lung Disease
Conditions: Lung Disease;   Chronic Obstructive Pulmonary Disease (COPD);   Asthma
Intervention:
2 Unknown  Race, Ethnicity, and Diffuse Parenchymal Lung Disease
Conditions: Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Diffuse Parenchymal Lung Disease
Intervention:
3 Terminated Detection and Characterization of Pulmonary Disease by Transthoracic Doppler (TTD)
Conditions: Lung Disease, Chronic Obstructive;   Lung Disease, Interstitial
Intervention:
4 Recruiting Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Lung Disease
Conditions: Chronic Obstructive Lung Disease (n=10);   Interstitial Lung Disease (n=10)
Intervention: Other: Whole body vibration
5 Active, not recruiting Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Conditions: Lung Diseases, Obstructive;   Pulmonary Disease, Chronic Obstructive;   Bronchitis, Chronic
Intervention: Device: Yamax Digi-Walker CW-700
6 Active, not recruiting Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive;   Pulmonary Emphysema;   Bronchitis, Chronic;   Lung Diseases;   Disease Progression
Intervention:
7 Completed A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases;   Lung Diseases, Obstructive
Interventions: Drug: PF-00610355;   Drug: PF - 00610355;   Drug: PF- 00610355;   Drug: Placebo;   Drug: Salmeterol
8 Recruiting Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
Conditions: COPD;   COPD Exacerbation;   Lung Diseases;   Respiratory Disorders;   Pulmonary Disease;   Chronic Obstructive Lung Diseases;   Chronic Obstructive Airway Disease
Interventions: Drug: Roflumilast;   Drug: Placebo
9 Enrolling by invitation Minimally Invasive Endoscopy in Diffuse Lung Disease
Conditions: Lung Disease;   Lung Cancer
Intervention: Procedure: Confocal microscopy and endocytoscopy
10 Unknown  Database of Interstitial Lung Diseases
Condition: Interstitial Lung Diseases
Intervention:
11 Completed Biomarkers in the Evaluation of Chronic Lung Disease
Conditions: Pulmonary Hypertension;   Pulmonary Arterial Hypertension;   Interstitial Lung Disease
Interventions: Other: Blood Gas;   Other: Pulmonary Exercise Test;   Other: Spirometry;   Other: Breath Condensate Collector
12 Recruiting A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma
Condition: Lung Diseases, Interstitial
Interventions: Drug: Tadalafil;   Drug: Placebo
13 Unknown  Evaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung Disease
Condition: Lung Disease
Intervention: Other: The Hospital2Home Service
14 Unknown  Biomarker in Lung Diseases
Condition: Lung Diseases
Intervention: Other: biomarker
15 Recruiting A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Conditions: Interstitial Lung Diseases;   Idiopathic Pulmonary Fibrosis;   Sarcoidosis
Intervention:
16 Recruiting Cryobiopsy vs. VATS in Diagnosis of Interstitial Lung Diseases
Condition: Interstitial Lung Disease
Intervention:
17 Completed The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
Condition: Interstitial Lung Disease
Intervention: Other: Pulmonary rehabilitation
18 Recruiting Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease
Conditions: Systemic Sclerosis;   Scleroderma;   Interstitial Lung Disease;   Lung Fibrosis
Interventions: Drug: Cyclophosphamide;   Drug: Placebo
19 Completed Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)
Conditions: Asthma;   COPD;   Interstitial Lung Disease;   Cystic Fibrosis;   Lung Cancer
Intervention:
20 Unknown  Specific Autoantibody Testing in Patients With Interstitial Lung Disease
Condition: Interstitial Lung Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years